Clinical Trials Directory

Trials / Completed

CompletedNCT03575312

Pharmacokinetics of Enrofloxacin in Plasma and Urine

Pharmacokinetic Study to Assess and Compare the Pharmacokinetics of Enrofloxacin After Dermal, Inhaled, and Oral Dosing

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
6 (actual)
Sponsor
Fraunhofer-Institute of Toxicology and Experimental Medicine · Academic / Other
Sex
Male
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

Antibiotics like enrofloxacin are widely used in animal farming to treat and prevent bacterial infections. A previous study in poultry farms has shown that yardmen show significant concentrations of administered antibiotics in their urine. It is currently unclear how poultry yardmen are exposed to the administered antibiotics. The objective of this exemplarily study is to obtain information on the pharmacokinetics of the different uptake routes (oral, inhaled or dermal).

Detailed description

Study subjects will be exposed to enrofloxacin at a concentration level representative for occupational exposure of yardmen at poultry farms. As three uptake-routes, oral, inhalation and dermal, are conceivable all three cases will be investigated. After administration blood and urine samples will be analysed for enrofloxacin and its main metabolite ciprofloxacin at several time points. The objective of this exemplarily study is to obtain information on the pharmacokinetics of the different uptake routes. If different exposure routes are characterized by different pharmacokinetics, such studies can be used to obtain a better understanding of general routes of exposure in occupational environments. On the basis of the results mitigation strategies can be developed, reducing the risk of exposure.

Conditions

Interventions

TypeNameDescription
DRUGEnrofloxacindermal application, inhalation rsp. oral administration of Enrofloxacin

Timeline

Start date
2018-04-27
Primary completion
2018-06-04
Completion
2018-08-30
First posted
2018-07-02
Last updated
2018-12-12

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03575312. Inclusion in this directory is not an endorsement.